Covid: Oxford jab protection against South Africa variant ‘limited’

Dr Michael Head, a senior research fellow in global health at the University of Southampton, said that if the Oxford-AstraZeneca vaccine was less protective against mild disease but prevented severe disease this would “still be a pretty good outcome”.



Source link